NEUROPACE, INC. (NPCE) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in CapitalUSD $577.15M; Retained Earnings (Accumulated Deficit)USD $-565.30M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in CapitalUSD $573.52M; Retained Earnings (Accumulated Deficit)USD $-559.10M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in CapitalUSD $571.41M; Retained Earnings (Accumulated Deficit)USD $-552.41M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $33.00K; Additional Paid in CapitalUSD $568.17M; Retained Earnings (Accumulated Deficit)USD $-549.69M.
NEUROPACE, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Accumulated Other Comprehensive Income (Loss), Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $34.00K | $577.15M | $-565.30M | $11.88M | (m) | (m) | 3 month · $2.30M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $34.00K | $573.52M | $-559.10M | $14.45M | (m) | (m) | 3 month · $2.28M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $34.00K | $571.41M | $-552.41M | $19.03M | (m) | (m) | 12 month · $11.09M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $33.00K | $568.17M | $-549.69M | $18.52M | (m) | (m) | 3 month · $2.63M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $33.00K | $565.60M | $-546.19M | $19.44M | (m) | (m) | 3 month · $3.23M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $33.00K | $561.77M | $-537.54M | $24.27M | (m) | (m) | 3 month · $2.63M | (m) | (m) | (m) |
| 2025-02-28 | (m) | (m) | (m) | (m) | (m) | 1 month · $49.50M | (m) | (m) | 1 month · 5.27M | 1 month · 9.40 | (m) |
| 2024-12-31 | $0.00 | $30.00K | $538.93M | $-530.95M | $8.01M | (m) | 12 month · $212.00K | 12 month · $10.28M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $30.00K | $535.49M | $-525.70M | $9.82M | (m) | 3 month · $189.00K | 3 month · $2.59M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $29.00K | $530.10M | $-520.25M | $9.88M | (m) | (m) | 3 month · $2.55M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $29.00K | $527.05M | $-512.73M | $14.34M | (m) | (m) | 3 month · $2.54M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $28.00K | $524.43M | $-503.81M | $20.65M | (m) | 12 month · $509.00K | 12 month · $9.56M | (m) | (m) | $0.00 |
| 2023-09-30 | $0.00 | $26.00K | $513.95M | $-497.61M | $16.36M | (m) | (m) | 3 month · $2.42M | (m) | (m) | $0.00 |
| 2023-06-30 | $0.00 | $26.00K | $511.55M | $-490.35M | $21.23M | (m) | (m) | 3 month · $2.65M | (m) | (m) | $0.00 |
| 2023-03-31 | $0.00 | $25.00K | $508.69M | $-481.23M | $27.49M | (m) | (m) | 3 month · $2.12M | (m) | (m) | $0.00 |
| 2022-12-31 | $0.00 | $25.00K | $506.71M | $-470.85M | $34.78M | (m) | (m) | 12 month · $8.35M | (m) | (m) | $-1.11M |
| 2022-09-30 | $0.00 | $25.00K | $504.43M | $-459.71M | $43.41M | (m) | (m) | 3 month · $2.18M | (m) | (m) | $-1.33M |
| 2022-06-30 | $0.00 | $25.00K | $502.25M | $-447.92M | $52.90M | (m) | (m) | 3 month · $2.60M | (m) | (m) | $-1.45M |
| 2022-03-31 | $0.00 | $24.00K | $499.01M | $-435.23M | $62.82M | (m) | (m) | 3 month · $1.49M | (m) | (m) | $-982.00K |
| 2021-12-31 | $0.00 | $24.00K | $497.52M | $-423.77M | $73.50M | (m) | (m) | 12 month · $4.29M | (m) | (m) | $-272.00K |
| 2021-09-30 | $0.00 | $24.00K | $494.73M | $-413.08M | $81.71M | (m) | (m) | 3 month · $1.11M | (m) | (m) | $33.00K |
| 2021-06-30 | $0.00 | $24.00K | $493.63M | $-405.00M | $88.67M | (m) | (m) | 3 month · $1.10M | (m) | (m) | $11.00K |
| 2021-03-31 | (m) | $0.00 | $240.03M | $-396.50M | $-156.44M | (m) | (m) | 3 month · $202.00K | (m) | (m) | $33.00K |
| 2020-12-31 | $0.00 | $0.00 | $239.83M | $-387.69M | $-147.83M | (m) | (m) | 12 month · $1.38M | (m) | (m) | $33.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-143.74M | (m) | (m) | 3 month · $301.00K | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-144.29M | (m) | (m) | 3 month · $290.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-135.82M | (m) | (m) | 3 month · $301.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $-129.35M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |